Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 24 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $34.200 million which beat the analyst consensus estimate of $32.016 million by 6.82 percent. This is a 5.02 percent increase over sales of $32.564 million the same period last year.